Artera, a company that develops multimodal AI-based prognostic and predictive cancer tests, has been granted Breakthrough Device Designation by the FDA for its ArteraAI Prostate, an AI-enabled tool ...
SAN FRANCISCO--(BUSINESS WIRE)--Artera, a developer of multimodal AI-based prognostic and predictive cancer tests, today announced the commercial launch of the ArteraAI Prostate Test (Post‑RP) for ...
Urine test using AI detects prostate cancer early with 92% accuracy, offering a better option than PSA tests. (CREDIT: AI-Generated / The Brighter Side of News) Prostate cancer is one of the most ...
A new artificial intelligence (AI) test can identify which men with prostate cancer will benefit most from the life-extending drug abiraterone, in clinical trial results presented by scientists from ...
California-based Artera, a company that develops multimodal AI-based prognostic and predictive cancer tests, has been granted de novo authorization by the FDA for its AI tool for prostate cancer ...
UK-based Lucida Medical has raised £8.7m ($11.4m) to advance its artificial intelligence (AI)-based software for prostate cancer diagnosis. VC firm IW Capital served as Lucida’s lead investor, while ...
SYRACUSE, N.Y.--(BUSINESS WIRE)--Associated Medical Professionals (A.M.P.) announced today the availability of the ArteraAI Prostate Test, an AI-powered risk stratification tool to help personalize ...
In this episode of eSpeaks, Jennifer Margles, Director of Product Management at BMC Software, discusses the transition from traditional job scheduling to the era of the autonomous enterprise. eSpeaks’ ...
Myriad Genetics, Inc. has announced a strategic collaboration with PATHOMIQ, Inc., which allows Myriad to exclusively license PATHOMIQ_PRAD, an AI technology platform for prostate cancer diagnostics ...
Increasing use of blood tests to detect prostate cancer is leading to overworked doctors. NTNU has now created an AI diagnostic tool that can help lighten the burden. Diagnostic tools based on ...
Newser on MSN
Review may shift narrative on prostate screening
A comprehensive new review of cases may give a once-dismissed prostate cancer test a boost, reports STAT News. An updated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results